MedPath

A randomized controlled trial using exercise to reduce gestational diabetes and other adverse maternal and neonatal outcomes in obese pregnant women –The pilot study.

Phase 1
Conditions
Obese Pregnant Women
Diet and Nutrition - Obesity
Reproductive Health and Childbirth - Other reproductive health and childbirth disorders
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12606000271505
Lead Sponsor
Royal Brisbane and Women's Hospital (RBWH) Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

Pregnant, less than 12 weeks gestationBMI 30 or greater. Willing and able to be randomized to an exercise intervention. Able to provide informed consent

Exclusion Criteria

Contraindication or inability to exercise.Not able to speak English.Medical or obstetric contraindication to exercise including haemodynamically significant heart disease, restrictive lung disease, incompetent cervix (cerclage), multiple gestation, severe anaemia, chronic bronchitis, type 1 diabetes, orthopaedic limitations, poorly controlled seizure disorder, poorly controlled hyperthyroidism, heavy smoker [ACOG guidelines].

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath